J
Jos op 't Roodt
Researcher at Maastricht University
Publications - 23
Citations - 1817
Jos op 't Roodt is an academic researcher from Maastricht University. The author has contributed to research in topics: Blood pressure & Pulse wave velocity. The author has an hindex of 12, co-authored 19 publications receiving 1643 citations. Previous affiliations of Jos op 't Roodt include Leiden University Medical Center & Boston Children's Hospital.
Papers
More filters
Journal ArticleDOI
Clusters of Comorbidities Based on Validated Objective Measurements and Systemic Inflammation in Patients with Chronic Obstructive Pulmonary Disease
Lowie E.G.W. Vanfleteren,Martijn A. Spruit,Miriam T.J. Groenen,Swetlana Gaffron,Vanessa P. M. van Empel,Piet L.B. Bruijnzeel,Erica P.A. Rutten,Jos op 't Roodt,Emiel F.M. Wouters,Frits M.E. Franssen +9 more
TL;DR: Multimorbidity is common in patients with COPD, and different comorbidite clusters can be identified, and low-grade systemic inflammation is mostly comparable among comor bidities.
Journal ArticleDOI
Early statin therapy restores endothelial function in children with familial hypercholesterolemia.
Saskia de Jongh,Marc R. Lilien,Jos op 't Roodt,Erik S.G. Stroes,Henk D. Bakker,John J.P. Kastelein +5 more
TL;DR: In this article, a study was designed to determine whether simvastatin improves endothelial function in children with familial hypercholesterolemia (FH) by measuring flow-mediated dilation of the brachial artery (FMD).
Journal ArticleDOI
Hypertension and Rarefaction during Treatment with Telatinib, a Small Molecule Angiogenesis Inhibitor
Neeltje Steeghs,Hans Gelderblom,Jos op 't Roodt,O. Christensen,Prabhu Rajagopalan,Marcel Hovens,Hein Putter,Ton J. Rabelink,Eelco J.P. de Koning +8 more
TL;DR: The increase in blood pressure observed in the treatment with telatinib, an angiogenesis inhibitor, may be caused by functional or structural rarefaction.
Journal ArticleDOI
Comparison of rosiglitazone and metformin for treating HIV lipodystrophy: a randomized trial.
Jeroen P.H. van Wijk,Eelco J.P. de Koning,Manuel Castro Cabezas,Jos op 't Roodt,Jorge Joven,Ton J. Rabelink,Andy I.M. Hoepelman +6 more
TL;DR: A randomized study to compare the effects of rosiglitazone and metformin on insulin sensitivity, body fat distribution, and endothelial function in patients with HIV lipodystrophy among 39 HIV-infected men between 18 and 70 years of age.
Journal ArticleDOI
Functional and Structural Markers of Atherosclerosis in Human Immunodeficiency Virus-Infected Patients
Jeroen P.H. van Wijk,Eelco J.P. de Koning,Manuel Castro Cabezas,Jorge Joven,Jos op 't Roodt,Ton J. Rabelink,Andy M. Hoepelman +6 more
TL;DR: The data of the present study suggest an increased cardiovascular risk in HIV-infected patients, even in the absence of clustering of metabolic risk variables.